EHC vs. SEM, VKTX, CHE, LEGN, HSIC, PEN, ROIV, BIO.B, BIO, and RGEN
Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Viking Therapeutics (VKTX), Chemed (CHE), Legend Biotech (LEGN), Henry Schein (HSIC), Penumbra (PEN), Roivant Sciences (ROIV), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), and Repligen (RGEN). These companies are all part of the "medical" sector.
Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability.
Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.
In the previous week, Encompass Health had 8 more articles in the media than Select Medical. MarketBeat recorded 21 mentions for Encompass Health and 13 mentions for Select Medical. Encompass Health's average media sentiment score of 0.79 beat Select Medical's score of 0.71 indicating that Select Medical is being referred to more favorably in the media.
Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 23.8% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Select Medical presently has a consensus target price of $34.25, suggesting a potential upside of 1.96%. Encompass Health has a consensus target price of $90.29, suggesting a potential upside of 4.34%. Given Select Medical's stronger consensus rating and higher probable upside, analysts plainly believe Encompass Health is more favorable than Select Medical.
Select Medical has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.
89.5% of Select Medical shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 19.1% of Select Medical shares are owned by insiders. Comparatively, 2.1% of Encompass Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Encompass Health has a net margin of 7.60% compared to Encompass Health's net margin of 3.97%. Encompass Health's return on equity of 18.11% beat Select Medical's return on equity.
Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.
Summary
Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.
Get Encompass Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Encompass Health Competitors List
Related Companies and Tools